Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Zolkind

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Molecular & Cellular Proteomics : MCP|September 16, 2023
Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCCNathan T Wamsley, Emily M Wilkerson, Li Guan, et al.
Cancer Discovery|December 19, 2025
A covalent allosteric molecular glue suppresses NRF2-dependent cancer growthNilotpal Roy, Tine Wyseure, I-Chung Lo, et al.
Oral Oncology|August 10, 2025
Establishing an integrated approach to head and neck cancer treatment and prevention: The Robert Ebert and Greg Stubblefield Head and Neck Tumor Center ModelAshwath Ashok, Sandra Dimitri, Karolina Plonowska-Hirschfeld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Molecular & Cellular Proteomics : MCP|September 16, 2023
Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCCNathan T Wamsley, Emily M Wilkerson, Li Guan, et al.
Cancer Discovery|December 19, 2025
A covalent allosteric molecular glue suppresses NRF2-dependent cancer growthNilotpal Roy, Tine Wyseure, I-Chung Lo, et al.
Oral Oncology|August 10, 2025
Establishing an integrated approach to head and neck cancer treatment and prevention: The Robert Ebert and Greg Stubblefield Head and Neck Tumor Center ModelAshwath Ashok, Sandra Dimitri, Karolina Plonowska-Hirschfeld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Pageof 4